Amiodarone and SARS-CoV-2 infection/COVID-19: UTILITY?

Abuabara-Franco E, Bohórquez-Rivero J, Restom-Arrieta J, Sáenz-López J, Correa-Guerero J, Mendoza-Paternina C. Consideraciones actuales de antimaláricos en la infección por SARS-CoV-2 y su impacto. Rev. Colomb. Nefrol; 2020 [citado 2020 Jul];7(Supl.2). Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/406.

Aimo A, Baritussio A, Emdin M, Tascini C. Amiodarone as a possible therapy for coronavirus infection. Eur J Prev Cardiol. 2020. https://doi.org/10.1177/2047487320919233.

Stadler K, Ha HR, Ciminale V, Spirli C, Saletti G, Schiavon M, et al. Amiodarone alters late endosomes and inhibits SARS coronavirus nfection at a post-endosomal level. Am J Respir Cell Mol Biol. 2008;39(2):142-9. https://doi.org/10.1165/rcmb.2007-0217OC.

Guo Y, Cao Q, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0

Wang L, Wang Y, Ye D, Liu Q. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents; 2020;55(6):105948. https://doi.org/10.1016/j.ijantimicag.2020.105948.

Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6. https://doi.org/10.1016/j.ijsu.2020.02.034.

Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrobl Agents. 2020;55(5):105938. https://doi.org/10.1016/j.ijantimicag.2020.105938.

Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29 https://doi.org/10.1186/s40249-020-00646-x.

Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2020. https://doi.org/10.1016/j.jmii.2020.03.022.

. Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents. 2020;55(5):105960. https://doi.org/10.1016/j.ijantimicag.2020.105960 .

Gehring G, Rohrmann k, Atenchong N, Mittler E, Becker S, Dahlmann F, et al. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother. 2014;69(8):2123-31. https://doi.org/10.1093/jac/dku091.

Bohorquez-Rivero JJ, Alvear.Orózco AS, Rivera-Moreno MM, Rivera.Moreno E, Restom-Arrieta JG. Amiodarona y su Papel en la Disfunción Tiroidea: La Importancia del Conocimiento y Seguimiento. Archivos de Medicina. 2019;15:4(6). https://doi.org/10.3823/1420.

Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144:213-21. https://doi.org/10.1159/000507305.

Rali AS, Sauer AJ. COVID-19 Pandemic and Cardiovascular Disease. US CardiologyReview. 2020;14:E01.

https://doi.org/10.15420/usc.2020.14.